 Valneva SE NASDAQ: VALN has signed an Advance Purchase Agreement APA with the European Commission EC to supply up to 60 million doses of its inactivated COVID-19 vaccine candidate VLA2001, over two years. The agreement follows the announcement made earlier this month that the EC had approved the APA. 